Literature DB >> 29889235

Contemporary Medical Management of Acute Severe Ulcerative Colitis.

Kaitlin G Whaley1, Michael J Rosen1,2.   

Abstract

Acute severe ulcerative colitis is a medical emergency that requires prompt recognition, evaluation, and intervention. Patients require hospital admission with laboratory, radiographic, and endoscopic evaluation with initiation of corticosteroid treatment. Despite early intervention, many patients require salvage medical therapy, with some progressing to colectomy. Here we review important concepts and recent advances in the evaluation and medical management of adult and pediatric patients with acute severe ulcerative colitis.

Entities:  

Mesh:

Year:  2019        PMID: 29889235      PMCID: PMC6290785          DOI: 10.1093/ibd/izy208

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  99 in total

1.  A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.

Authors:  Bruce E Sands; William J Sandborn; Brian Feagan; Robert Löfberg; Toshifumi Hibi; Tao Wang; Lisa-Marie Gustofson; Cindy J Wong; Margaret K Vandervoort; Stephen Hanauer
Journal:  Gastroenterology       Date:  2008-04-25       Impact factor: 22.682

2.  Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.

Authors:  R W Chapman; W S Selby; D P Jewell
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

3.  Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.

Authors:  Uri Kopylov; Konstantinos Papamichael; Konstantinos Katsanos; Matti Waterman; Ariella Bar-Gil Shitrit; Trine Boysen; Francisco Portela; Armando Peixoto; Andrew Szilagyi; Marco Silva; Giovanni Maconi; Ofir Har-Noy; Peter Bossuyt; Gerassimos Mantzaris; Manuel Barreiro de Acosta; Maria Chaparro; Dimitrios K Christodoulou; Rami Eliakim; Jean-Francois Rahier; Fernando Magro; David Drobne; Marc Ferrante; Elena Sonnenberg; Britte Siegmund; Vinciane Muls; Tamara Thurm; Henit Yanai; Iris Dotan; Tim Raine; Avi Levin; Eran Israeli; Fahd Ghalim; Franck Carbonnel; Severine Vermeire; Shomron Ben-Horin; Xavier Roblin
Journal:  Inflamm Bowel Dis       Date:  2017-09       Impact factor: 5.325

4.  Predicting outcome in severe ulcerative colitis.

Authors:  S P Travis; J M Farrant; C Ricketts; D J Nolan; N M Mortensen; M G Kettlewell; D P Jewell
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

5.  Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.

Authors:  Katsuyoshi Matsuoka; Yasushi Iwao; Takeshi Mori; Atsushi Sakuraba; Tomoharu Yajima; Tadakazu Hisamatsu; Susumu Okamoto; Yuichi Morohoshi; Motoko Izumiya; Hitoshi Ichikawa; Toshiro Sato; Nagamu Inoue; Haruhiko Ogata; Toshifumi Hibi
Journal:  Am J Gastroenterol       Date:  2006-12-11       Impact factor: 10.864

6.  Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort.

Authors:  Graham Morrison; D R Van Langenberg; S J Gibson; P R Gibson
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

7.  Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis.

Authors:  Omoniyi J Adedokun; William J Sandborn; Brian G Feagan; Paul Rutgeerts; Zhenhua Xu; Colleen W Marano; Jewel Johanns; Honghui Zhou; Hugh M Davis; Freddy Cornillie; Walter Reinisch
Journal:  Gastroenterology       Date:  2014-08-28       Impact factor: 22.682

Review 8.  Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis.

Authors:  Uri Kopylov; Noa Eliakim-Raz; Andrew Szilagy; Ernest Seidman; Shomron Ben-Horin; Lior Katz
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

9.  Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.

Authors:  Gary R Lichtenstein; Brian G Feagan; Russell D Cohen; Bruce A Salzberg; Robert H Diamond; Samiyeh Price; Wayne Langholff; Anil Londhe; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2012-08-14       Impact factor: 10.864

10.  Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series.

Authors:  Mohamed Bekheit; Nahed Baddour; Khaled Katri; Yousry Taher; Khaled El Tobgy; Essam Mousa
Journal:  BMJ Open Gastroenterol       Date:  2016-04-28
View more
  2 in total

1.  Sarcopenia assessed by computed tomography is associated with colectomy in patients with acute severe ulcerative colitis.

Authors:  Xiaolong Ge; Jingya Xia; Yan Wu; Linna Ye; Wei Liu; Weilin Qi; Qian Cao; Rongpan Bai; Wei Zhou
Journal:  Eur J Clin Nutr       Date:  2021-06-15       Impact factor: 4.016

2.  Glucocorticoids Promote the Onset of Acute Experimental Colitis and Cancer by Upregulating mTOR Signaling in Intestinal Epithelial Cells.

Authors:  Zhengguo Zhang; Lin Dong; Anna Jia; Xi Chen; Qiuli Yang; Yufei Wang; Yuexin Wang; Ruichen Liu; Yejin Cao; Ying He; Yujing Bi; Guangwei Liu
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.